Berlin, Aug 9 (AP) German pharmaceutical maker BioNTech, which developed the first widely used coronavirus vaccine with Pfizer, saw its profits surge in the second quarter of 2021.

The Mainz-based company said Monday that it made a net profit of almost 2.8 billion euros (USD 3.3 billion) from April to June.

Also Read | Taliban Captures Afghanistan’s Samangan Province Capital Aybak City as Violence Intensifies.

This boosted first-half net profits to over 3.9 billion euros, compared with a net loss of almost 142 million euros in the first six months of 2020.

The company has said the windfall from its mRNA-based coronavirus vaccine will help it to develop drugs against cancer and other diseases. (AP)

Also Read | PM Narendra Modi to Chair UNSC High-Level Open Debate on Maritime Security, Russian President Vladimir Putin to Participate.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)